US Stock MarketDetailed Quotes

TXMD TherapeuticsMD

Watchlist

1.860
-0.010-0.53%

Close Apr 26 16:00 ET

1.860
0.0000.00%

Post 19:33 ET

21.45MMarket Cap-1897P/E (TTM)

TherapeuticsMD Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-346.67%-23.1M

-116.47%-4.98M

-134.03%-6.03M

83.63%-3.39M

51.31%-8.7M

116.99%9.37M

-37.00%30.24M

146.35%17.72M

21.90%-20.72M

53.43%-17.87M

Net income from continuing operations

-816.85%-7.7M

-103.18%-1.54M

90.20%-1.43M

83.77%-2.41M

87.08%-2.31M

101.35%1.07M

-3.38%48.45M

69.15%-14.63M

65.13%-14.87M

54.61%-17.88M

Depreciation and amortization

-25.00%900K

94.62%615K

-52.75%129K

-54.26%129K

-91.79%27K

63.04%1.2M

113.42%316K

-73.50%273K

-72.94%282K

-67.71%329K

Other non cash items

73.32%-107K

-68.09%-632K

6,130.00%603K

-125.00%-18K

-757.14%-60K

-155.69%-401K

92.83%-376K

-100.43%-10K

-100.49%-8K

-100.35%-7K

Change In working capital

-326.97%-17.45M

83.64%-3.46M

-120.01%-5.56M

81.73%-1.53M

-189.92%-6.9M

-189.00%-4.09M

-3,367.70%-21.14M

1,849.02%27.79M

-177.90%-8.36M

54.17%-2.38M

-Change in prepaid assets

222.42%2M

1,333.63%3.24M

-114.79%-1.39M

115.93%1.6M

-238.12%-1.45M

155.11%620K

-86.75%226K

394.31%9.41M

-951.44%-10.06M

228.76%1.05M

-Change in payables and accrued expense

-684.99%-17.85M

68.11%-4.46M

-128.79%-5.37M

-301.53%-3.69M

-25.93%-4.32M

-14.71%3.05M

-65.61%-14M

233.50%18.65M

-80.48%1.83M

-16.18%-3.43M

-Change in other current assets

85.25%-1.13M

69.74%-2.31M

--721K

--483K

---19K

---7.64M

--0

-Change in other current liabilities

-289.26%-471K

-71.21%76K

283.85%478K

164.80%81K

---1.11M

-105.66%-121K

-80.88%264K

-165.00%-260K

---125K

--0

Cash from discontinued investing activities

Operating cash flow

-346.62%-23.08M

-116.40%-4.96M

-134.03%-6.03M

83.63%-3.39M

51.31%-8.7M

106.56%9.36M

176.43%30.24M

146.35%17.72M

21.90%-20.72M

53.43%-17.87M

Investing cash flow

Cash flow from continuing investing activities

84.03%-355K

95.11%-74K

103.85%7K

14.61%-76K

51.60%-212K

Net PPE purchase and sale

----

--0

----

--0

151.22%21K

33.33%-42K

Net intangibles purchase and sale

--0

83.78%-355K

93.73%-95K

102.78%7K

-102.08%-97K

54.67%-170K

Cash from discontinued investing activities

Investing cash flow

--0

84.03%-355K

95.11%-74K

103.85%7K

14.61%-76K

51.60%-212K

Financing cash flow

Cash flow from continuing financing activities

101.34%3.15M

101.79%2M

-100.06%-1K

100.96%1.15M

-281.55%-235.21M

-8,373.84%-111.95M

-94.54%1.74M

-28,137.38%-120M

-105.21%-5M

Net issuance payments of debt

--0

-338.86%-219.43M

---94.43M

--0

---120M

90.00%-5M

Net common stock issuance

27.67%3.15M

14,200.00%2M

-100.04%-1K

----

-98.66%2.47M

-98.95%14K

-92.32%2.45M

----

Net preferred stock issuance

--0

----

---16.97M

----

Net other financing activities

----

75.21%-1.27M

---540K

----

Cash from discontinued financing activities

Financing cash flow

101.34%3.15M

101.79%2M

-100.06%-1K

100.96%1.15M

--0

-281.55%-235.21M

-8,373.84%-111.95M

-94.54%1.74M

-28,137.38%-120M

-105.21%-5M

Net cash flow

Beginning cash position

-24.27%49.32M

-73.48%10.17M

-47.80%13.73M

-43.23%17.25M

-24.27%49.32M

-19.09%65.12M

-63.44%38.33M

-76.39%26.3M

-77.92%30.38M

-19.09%65.12M

Current changes in cash

-184.66%-44.99M

-153.14%-5.84M

-129.63%-3.56M

13.77%-3.52M

7.68%-32.07M

-2.87%-15.81M

127.66%10.99M

282.70%12.03M

84.42%-4.08M

-160.80%-34.74M

End cash Position

-91.23%4.33M

-73.48%10.17M

-47.80%13.73M

-43.23%17.25M

-24.27%49.32M

-63.44%38.33M

-76.39%26.3M

-77.92%30.38M

Free cash flow

-356.34%-23.08M

-116.44%-4.96M

-134.01%-6.03M

83.69%-3.39M

51.89%-8.7M

106.21%9M

173.44%30.16M

146.15%17.72M

21.88%-20.8M

53.41%-18.08M

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-346.67%-23.1M	-116.47%-4.98M	-134.03%-6.03M	83.63%-3.39M	51.31%-8.7M	116.99%9.37M	-37.00%30.24M	146.35%17.72M	21.90%-20.72M	53.43%-17.87M
Net income from continuing operations	-816.85%-7.7M	-103.18%-1.54M	90.20%-1.43M	83.77%-2.41M	87.08%-2.31M	101.35%1.07M	-3.38%48.45M	69.15%-14.63M	65.13%-14.87M	54.61%-17.88M
Depreciation and amortization	-25.00%900K	94.62%615K	-52.75%129K	-54.26%129K	-91.79%27K	63.04%1.2M	113.42%316K	-73.50%273K	-72.94%282K	-67.71%329K
Other non cash items	73.32%-107K	-68.09%-632K	6,130.00%603K	-125.00%-18K	-757.14%-60K	-155.69%-401K	92.83%-376K	-100.43%-10K	-100.49%-8K	-100.35%-7K
Change In working capital	-326.97%-17.45M	83.64%-3.46M	-120.01%-5.56M	81.73%-1.53M	-189.92%-6.9M	-189.00%-4.09M	-3,367.70%-21.14M	1,849.02%27.79M	-177.90%-8.36M	54.17%-2.38M
-Change in prepaid assets	222.42%2M	1,333.63%3.24M	-114.79%-1.39M	115.93%1.6M	-238.12%-1.45M	155.11%620K	-86.75%226K	394.31%9.41M	-951.44%-10.06M	228.76%1.05M
-Change in payables and accrued expense	-684.99%-17.85M	68.11%-4.46M	-128.79%-5.37M	-301.53%-3.69M	-25.93%-4.32M	-14.71%3.05M	-65.61%-14M	233.50%18.65M	-80.48%1.83M	-16.18%-3.43M
-Change in other current assets	85.25%-1.13M	69.74%-2.31M	--721K	--483K	---19K	---7.64M	---7.64M	--0	--0	--0
-Change in other current liabilities	-289.26%-471K	-71.21%76K	283.85%478K	164.80%81K	---1.11M	-105.66%-121K	-80.88%264K	-165.00%-260K	---125K	--0
Cash from discontinued investing activities
Operating cash flow	-346.62%-23.08M	-116.40%-4.96M	-134.03%-6.03M	83.63%-3.39M	51.31%-8.7M	106.56%9.36M	176.43%30.24M	146.35%17.72M	21.90%-20.72M	53.43%-17.87M
Investing cash flow
Cash flow from continuing investing activities	0	0	0	0	0	84.03%-355K	95.11%-74K	103.85%7K	14.61%-76K	51.60%-212K
Net PPE purchase and sale	----	----	--0	--0	--0	----	----	--0	151.22%21K	33.33%-42K
Net intangibles purchase and sale	--0	--0	--0	--0	--0	83.78%-355K	93.73%-95K	102.78%7K	-102.08%-97K	54.67%-170K
Cash from discontinued investing activities
Investing cash flow	--0	--0	--0	--0	--0	84.03%-355K	95.11%-74K	103.85%7K	14.61%-76K	51.60%-212K
Financing cash flow
Cash flow from continuing financing activities	101.34%3.15M	101.79%2M	-100.06%-1K	100.96%1.15M	0	-281.55%-235.21M	-8,373.84%-111.95M	-94.54%1.74M	-28,137.38%-120M	-105.21%-5M
Net issuance payments of debt	--0	--0	--0	--0	--0	-338.86%-219.43M	---94.43M	--0	---120M	90.00%-5M
Net common stock issuance	27.67%3.15M	14,200.00%2M	-100.04%-1K	----	----	-98.66%2.47M	-98.95%14K	-92.32%2.45M	----	----
Net preferred stock issuance	--0	----	----	----	----	---16.97M	----	----	----	----
Net other financing activities	----	----	----	----	----	75.21%-1.27M	---540K	----	----	----
Cash from discontinued financing activities
Financing cash flow	101.34%3.15M	101.79%2M	-100.06%-1K	100.96%1.15M	--0	-281.55%-235.21M	-8,373.84%-111.95M	-94.54%1.74M	-28,137.38%-120M	-105.21%-5M
Net cash flow
Beginning cash position	-24.27%49.32M	-73.48%10.17M	-47.80%13.73M	-43.23%17.25M	-24.27%49.32M	-19.09%65.12M	-63.44%38.33M	-76.39%26.3M	-77.92%30.38M	-19.09%65.12M
Current changes in cash	-184.66%-44.99M	-153.14%-5.84M	-129.63%-3.56M	13.77%-3.52M	7.68%-32.07M	-2.87%-15.81M	127.66%10.99M	282.70%12.03M	84.42%-4.08M	-160.80%-34.74M
End cash Position	-91.23%4.33M	-91.23%4.33M	-73.48%10.17M	-47.80%13.73M	-43.23%17.25M	-24.27%49.32M	-24.27%49.32M	-63.44%38.33M	-76.39%26.3M	-77.92%30.38M
Free cash flow	-356.34%-23.08M	-116.44%-4.96M	-134.01%-6.03M	83.69%-3.39M	51.89%-8.7M	106.21%9M	173.44%30.16M	146.15%17.72M	21.88%-20.8M	53.41%-18.08M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall